Your browser doesn't support javascript.
loading
Corrigendum to "Optimizing choices and sequences in the diagnostic-therapeutic landscape of advanced triple-negative breast cancer: An Italian consensus paper and critical review" [Cancer Treat. Rev. 114 (2023) 102511].
Miglietta, F; Fabi, A; Generali, D; Dieci, M V; Arpino, G; Bianchini, G; Cinieri, S; Conte, P F; Curigliano, G; De Laurentiis, M; Del Mastro, L; De Placido, S; Gennari, A; Puglisi, F; Zambelli, A; Perrone, F; Guarneri, V.
Afiliação
  • Miglietta F; Department of Surgery, Oncology and Gastroenterology, University of Padova, Italy; Oncology Unit 2, Istituto Oncologico Veneto IOV-IRCCS, Padova, Italy.
  • Fabi A; Precision Medicine in Breast Cancer, Fondazione Policlinico Universitario A. Gemelli IRCCS Roma, Italy.
  • Generali D; Department of Medicine, Surgery and Health Sciences, University of Trieste, Italy; Multidisciplinary Unit of Breast Pathology and Translational Research, Cremona Hospital, Italy.
  • Dieci MV; Department of Surgery, Oncology and Gastroenterology, University of Padova, Italy; Oncology Unit 2, Istituto Oncologico Veneto IOV-IRCCS, Padova, Italy.
  • Arpino G; Department of Clinical Medicine and Surgery, University of Naples Federico II, Napoli, Italy.
  • Bianchini G; Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy; Università Vita-Salute San Raffaele, Milan, Italy.
  • Cinieri S; Oncologia Medica, Ospedale Senatore Antonio Perrino, Brindisi, Italy.
  • Conte PF; Rete Oncologica Veneta (ROV), Istituto Oncologico Veneto, Italy.
  • Curigliano G; Department of Oncology and Hemato-Oncology, University of Milano, Italy; Division of Early Drug Development, European Institute of Oncology, Milano, Italy.
  • De Laurentiis M; Department of Breast and Thoracic Oncology, National Cancer Institute, IRCCS "Fondazione G. Pascale", Naples, Italy.
  • Del Mastro L; Department of Medical Oncology, Breast Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy; Department of Internal Medicine and Medical Specialties (DIMI), School of Medicine, University of Genoa, Italy.
  • De Placido S; Department of Clinical Medicine and Surgery, University of Naples Federico II, Napoli, Italy.
  • Gennari A; Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy.
  • Puglisi F; Department of Medicine, University of Udine, Udine, Italy; Department of Medical Oncology, CRO Aviano, National Cancer Institute, IRCCS, Aviano, Italy.
  • Zambelli A; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy; Medical Oncology and Hematology Unit, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.
  • Perrone F; Clinical Trials Unit, National Cancer Institute, IRCCS "Fondazione G. Pascale", Naples, Italy.
  • Guarneri V; Department of Surgery, Oncology and Gastroenterology, University of Padova, Italy; Oncology Unit 2, Istituto Oncologico Veneto IOV-IRCCS, Padova, Italy. Electronic address: valentina.guarneri@unipd.it.
Cancer Treat Rev ; 119: 102594, 2023 Sep.
Article em En | MEDLINE | ID: mdl-37400291
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article